Synthetic DNA production platform with algorithm-driven manufacturing
Ribbon Bio operates a vertically integrated synthetic DNA platform built on cloud infrastructure (Azure, AWS, GCP) with heavy data and observability tooling (Elasticsearch, Prometheus, Grafana, Plotly, D3.js). Current hiring skews heavily toward data roles (3 of 6 open positions) focused on ETL workflows, production analytics dashboards, and data-pipeline reliability—indicating the company is scaling its operational data layer and moving from research into repeatable, instrumented manufacturing processes.
Ribbon Bio develops algorithm-driven synthetic DNA production technology for biotech and pharmaceutical partners. Founded in 2018 and based in Vienna, the company manufactures high-fidelity DNA molecules at scale. The platform spans production systems, quality-control workflows, and customer-facing analytics interfaces. Engineering efforts center on cloud-native data pipelines, CI/CD automation, and integration between business systems (Business Central) and production infrastructure, with a stated focus on supply-chain optimization and operational reliability.
Ribbon Bio runs Next.js, React, Python, FastAPI, and Node.js on Azure, AWS, and GCP. Infrastructure includes Docker, Kubernetes, GitHub Actions, GitLab CI/CD, Prometheus, Grafana, and Elasticsearch for observability.
Active projects include cloud-native data pipelines, CI/CD automation, observability stack implementation, production and QC dashboards, customer-facing analytics interfaces, and integration of business and manufacturing systems.
Other companies in the same industry, closest in size